+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Deferoxamine (CAS 70-51-9) Global Market Research Report 2024 - Product Thumbnail Image

Deferoxamine (CAS 70-51-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Deferasirox (CAS 201530-41-8) Global Market Research Report 2024 - Product Thumbnail Image

Deferasirox (CAS 201530-41-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Clorindione (CAS 1146-99-2) Global Market Research Report 2024 - Product Thumbnail Image

Clorindione (CAS 1146-99-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Carbasalate calcium (CAS 5749-67-7) Global Market Research Report 2024 - Product Thumbnail Image

Carbasalate calcium (CAS 5749-67-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Sickle Cell Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Sickle Cell Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • August 2024
  • 52 Pages
  • Global
Global Hemostasis Market Database for the US, Europe, Japan - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

Global Hemostasis Market Database for the US, Europe, Japan - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • March 2024
  • Global, Europe, United States, ... Global, Europe, United States, Japan
From
U.S. Hemoglobinopathies Market Size, Share & Trends Analysis Report by Type (Thalassemia, Sickle Cell Disease), Diagnosis (Thalassemia, Sickle Cell Disease), Therapy, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

U.S. Hemoglobinopathies Market Size, Share & Trends Analysis Report by Type (Thalassemia, Sickle Cell Disease), Diagnosis (Thalassemia, Sickle Cell Disease), Therapy, Region, and Segment Forecasts, 2024-2030

  • Report
  • June 2024
  • 80 Pages
  • United States
From
Hemophilia B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Hemophilia B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Hemophilia A Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Hemophilia A Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Europe T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Europe T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 78 Pages
  • Europe
From
Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Asia Pacific T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 76 Pages
  • Asia Pacific
From
North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 70 Pages
  • North America
From
Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

Middle East & Africa T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 90 Pages
  • Africa, Middle East
From
Latin America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Europe Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Europe
From
North America Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 120 Pages
  • North America
From
Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Middle East and Africa Hemoglobinopathies Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Middle East, Africa
From
Middle East Hemostasis Market Database for 11 Countries - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

Middle East Hemostasis Market Database for 11 Countries - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • March 2024
  • Middle East
From
North America Hemostasis Market Database for the US, Canada, Mexico - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

North America Hemostasis Market Database for the US, Canada, Mexico - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • March 2024
  • Canada, Mexico, North America Canada, Mexico, North America
From
Europe Hemostasis Market Database for France, Germany, Italy, Spain, UK - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests - Product Thumbnail Image

Europe Hemostasis Market Database for France, Germany, Italy, Spain, UK - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 40 Coagulation Tests

  • Report
  • March 2024
  • France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more